# data[].attributes.body
Adequate and proper blood sugar monitoring is integral to managing diabetes, both type 1 and type 2. Knowledge of the glucose levels measured can allow a patient to select an appropriate dose of insulin or implement dietary or other lifestyle changes to regulate their glucose levels(Nihaal et al.,2023). Over the past decade, there have been several advances in diabetes technology, such as continuous glucose monitoring (CGM) systems, insulin delivery devices, and hybrid closed-loop systems (Satish et al.,2022). One of the latest in these technologies is Dexcom 7. A seventh-generation (G7) CGM (Dexcom) was designed to improve the performance and usability aspects of the G6 CGM. (Satish et al.,2022).

# data[].attributes.body
In addition to the findings about Dexcom G7 from current research studies, when prompted ChatGpt with the question of the summary of the benefits of Dexcom G7 , Continuous Glucose Monitoring (CGM), the AI text generated indicated that Dexcom 7 developed to perform better and it provides the following advantages over its predecessor. I agree with these AI findings because they align with my conclusions of the research into the subject matter and personal experience with people who use this device.

1. Real-Time Data: Provides continuous glucose readings, allowing users to monitor their levels in real-time.

2. Alerts and Notifications: Can alert users to high or low glucose levels, helping to prevent dangerous situations.

3. Trend Analysis: Shows trends in glucose levels, helping users understand how their body responds to food, exercise, and medication.

4. Convenience: Reduces the need for frequent fingerstick blood tests, making it more convenient for daily management.

5. Integration with Other Devices: Can often be integrated with other devices like insulin pumps or smartphones, enhancing diabetes management.

6. User-Friendly: Typically features easy-to-read displays and user interfaces for managing and interpreting data.(Open AI, 2024)

# data[].attributes.body
According to this study of the accuracy of this device in managing blood glucose in patients with type 1 and type 2 diabetes, the G7 CGM described in this pivotal study was accurate and safe when inserted on either the upper arm or abdomen in adults with diabetes. In-clinic glucose manipulations and frequent blood glucose sampling confirmed accurate readings during euglycemia, hypoglycemia, and hyperglycemia (reflected as time in range [TIR], time below range [TBR], and time above range [TAR]), as well as during rapid glucose concentration change. Even at the highest rates of glucose concentration change, MARD values <10% were observed for arm-placed sensors and <10.5% for abdomen-placed sensors. There were no safety concerns during the study. ( Satish et al.,2022).

# data[].attributes.body
Garg, S. K., Kipnes, M., Castorino, K., Bailey, T. S., Akturk, H. K., Welsh, J. B., Christiansen, M. P., Balo, A. K., Brown, S. A., Reid, J. L., & Beck, S. E. (2022). Accuracy and Safety of Dexcom G7 Continuous Glucose Monitoring in Adults with Diabetes. Diabetes technology & therapeutics, 24(6), 373–380. https://doi.org/10.1089/dia.2022.0011

Reddy, N., Verma, N. & and Dungan, K. (2023 July 8). Monitoring Technologies- Continuous Glucose Monitoring, Mobile Technology, Biomarkers of Glycemic  Control. National Library of Medicine  https://www.nc.nlm.nih.gov/books/NBK279046/

Tomic, D., Shaw, J. E., & Magliano, D. J. (2022). The burden and risks of emerging complications of diabetes mellitus. Nature reviews. Endocrinology, 18(9), 525–539. https://doi.org/10.1038/s41574-022-00690-7

Open AI (2024). ChatGpt (Sept 20, Version). [ Large Language Model] https://chat.chatbotapp.ai/chats/-O7ReCpgK0X7ZJKNEp5r?model=gpt-3.5

# data[].attributes.headline
Dexcom G7 including an optional receiver and display unit.

# data[].attributes.subject
Dexcom G7 including an optional receiver and display unit.

# data[].attributes.body
G7 components (left to right) include an optional receiver and display unit, packaging, the wearable sensor/transmitter, and the applicator. The wearable measures 24 × 27.3 × 4.6 mm, roughly the size of three stacked quarters. G7, seventh generation.

# data[].attributes.body
Also, it is significant to mention here that Dexcom G7 Several aspects of G7 hardware and software are different from G6. The G7 sensor wire is shorter than G6 and is inserted at a steeper (90°) angle. The redesigned applicator allows for sensor deployment with one hand, and most participants found G7 easier to insert than their prior CGM system.( Satish et al.,2022). The Dexcom G7 offers significant benefits for managing diabetes, including real-time monitoring, improved accuracy, user-friendly features, and better integration with other tools, leading to improved overall health and well-being for individuals with diabetes.

# data[].attributes.body
Although the innovation in blood glucose management has numerous benefits for individuals with diabetes, it also has drawbacks. When asked about the disadvantages of Dexcom 7, ChatGPT generated the following response. I agree with it based on my research into the use of the device and my personal experience with individuals who use it.

1. Cost: CGM devices can be expensive, and insurance coverage may vary, making them less accessible to some users.

2. Calibration Needs: Depending on the model, some devices may require calibration with fingerstick tests.

3. Skin Irritation: Some users may experience skin irritation or allergic reactions from the adhesive attached to the sensor.

4. Accuracy Issues: While generally reliable, accuracy can sometimes be affected by factors such as hydration levels, pressure on the sensor, or sensor age.

5. Calibration and Maintenance: Regular maintenance and occasional sensor changes are required, which can be inconvenient.

6. Training: Users may need training to interpret data accurately and respond appropriately to trends.(Open AI,2024)

# data[].attributes.body
Living with diabetes brings significant complications, including vascular diseases like Coronary Artery Disease (CAD), Cerebrovascular Accident, Chronic Renal Disease, retinopathy, and neuropathy. However, in addition to the known complications, new research works have implicated diabetes in many other diseases. According to Tomic et al. (2022), studies have demonstrated notable links between diabetes mellitus and a broad range of comorbidities, including cognitive decline, functional disability, affective disorders, obstructive sleep apnea, and liver disease, and have refined our understanding of the association between diabetes mellitus and infection. In line with a situation like this at hand, anyone living with diabetes needs to have adequate control of their blood sugar.

Innovations like Dexcom 7 allow individuals with diabetes to monitor their blood glucose levels in real-time. This helps them make informed decisions about when to eat, what to eat, and how different foods affect their blood sugar levels. As a result, it can reduce the need for insulin and other antidiabetic drugs, and help them find the most effective exercise regimen to manage their blood sugar. In my experience, I've observed that using a device like this can also help people with diabetes lose weight more easily, as they can track their blood sugar levels continuously.

With the increased availability of devices like Dexcom 7, we expect to see a reduction in diabetes complications and fewer hospital admissions for people with diabetes.

# data[].attributes.body
Learner -Consistently learning new things; learning is a lifelong exercise.

Restorative: I always have in my mind that every problem has a solution.

Achiever: Driven, focused on accomplishing tasks, and has a strong work ethic.

Input - Keep collecting new pieces of information and make input through knowledge

Focus: "Where am I headed?” I ask myself this question every day: Guided by this theme of destination, I know is imperative to focus on my goal.